 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Adverse Events of HIV/HAART
General | Anemia | Bone Problems | Gastrointestinal Problems | Heart Disease and HIV | Fatigue | Facial Wasting/Lipoatrophy | Immune Reconstitution Syndrome | Insomnia | Hypersensitivity Reaction | Lipodystrophy and Other Metabolic Complications | Medication-Related Liver Problems| Neuropathy | Pancreatitis | Renal Complications | Lactic Acidosis | Sexual Dysfunction | Skin Complications | Women-Specific General HIV Complications | Other
See also: Structured HIV Treatment Interruptions
General
- Reporting Adverse Events to the U.S. Food and Drug Administration (December 20, 2007)
From U.S. Food and Drug Administration - Adverse Effects of Antiretroviral Drugs (November 2007)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite - Adverse Events Due to Non-Antiretroviral Medications During Treatment of HIV-Related Infections and Complications (May 2006)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite - Adverse Events of Antiretroviral Drugs (April 2006)
From AIDS Education & Training Centers National Resource Center - Severe Events Unrelated to AIDS or Antiretrovirals Were Most Common in Early HAART Patients (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Are People Getting the Help They Need for Side Effects? (Summer 2005)
Results from a 381-person survey of New Yorkers taking HIV treatment, with a focus on the impact of side effects.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - Five Ways to Tackle Toxicity (or the Ant, the Spider, and the Bee): 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (January 2005)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Not Undetectable, but Still Content (December 2004)
Some HIV-positive people have decided that the benefits of having an undetectable viral load don't outweigh the health risks of potent HIV medications.
In POZ - HAART Side Effects More Likely Among Those With High Viral Loads (July 6, 2004)
Up to 13% of HIV-positive people experience a severe side effect within a year after beginning HAART; side effects are likelier in those with baseline viral load over 100,000.
In aidsmap.com - Can Uridine Supplements Protect People With HIV/AIDS From Drug Toxicity? (April 29, 2004)
From Canadian AIDS Treatment Information Exchange - Surviving AIDS, but Still at Risk (March 7, 2004)
As most people with HIV know, antiretrovirals may prolong life, but they also carry their own dangers.
In Milwaukee Journal Sentinel - Complications of Antiretroviral Therapies and HIV (March 2004)
An examination of diabetes, kidney disease, bone problems and hypertension research from the February Retrovirus conference.
In Hopkins HIV Report - Why People With HIV Still Die -- And Why They Don't Have To (March 2004)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Drug Side Effects Chart (November 2003)
To read PDF, click here
From Project Inform - Testimony on Accelerated Approval: September 1994 (November 2003)
Carlton Hogan's warnings about the need to study long-term drug toxicities are as poignant today as they were nine years ago.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Protease Inhibitors and Severe Adverse Events (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - HIV 101: Chart of Common Toxicities Among Antiretrovirals (June 2003)
To read PDF, click here
In HEPP Report, from Brown Medical School - Long-Term Toxicities Associated With HIV and Antiretroviral Therapy (June 2003)
Brief overviews of many common HAART side effects.
To read PDF, click here
In HEPP Report, from Brown Medical School - Women and HIV: The Impact of Sex/Gender on Antiretroviral Therapy and Its Complications (Summer 2003)
Kathleen Squires, M.D., speaks at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Intentional Nonadherence to HAART Common Due to Side Effects, Study Finds (October 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study Examines Mortality Factors in HIV Patients on Protease Inhibitors (October 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Sex Hormones and HAART (April 11, 2002)
From Canadian AIDS Treatment Information Exchange - Emerging Complications of HIV Therapy (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Pancreatitis: An Emerging Complication of HCV Treatment in HIV Co-Infected Patients Treated With Didanosine/Stavudine Containing Regimens (December 17, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Study Finds Women More Likely to Get Rash With Nevirapine Than Men (August 16, 2001)
From Canadian AIDS Treatment Information Exchange - Does Efavirenz (Sustiva) Cause Breast Enlargement? (August 1, 2001)
From Canadian AIDS Treatment Information Exchange - Tattoos Flare Up From HAART (May 28, 2001)
From Canadian AIDS Treatment Information Exchange - A New Side Effect From Kaletra? (May 25, 2001)
From Canadian AIDS Treatment Information Exchange - High Blood Pressure With Indinavir (May 25, 2001)
From Canadian AIDS Treatment Information Exchange - Hearing Loss May Be Linked to Use of Nukes (May 16, 2001)
From Canadian AIDS Treatment Information Exchange - Vitamin Cocktail Helps People Recover From Nuke Side Effects (December 20, 2000)
From Canadian AIDS Treatment Information Exchange - Adverse Reactions to HIV Medications (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Other
- Light Sensitivity More Common Among People on HIV Treatment, Study Finds (April 26, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Long-Term Tenofovir Use May Be Associated With Mild Nephrotoxicity (May/June 2005)
From The Body PRO - Breast Enlargement in Men May Be Linked to d4T, ddI, Efavirenz (October 2004)
Quick recap of studies in the journal AIDS and The Breast Journal.
In HIV Treatment ALERTS!, from The Center for AIDS - Reasons for Early Abacavir Discontinuation in HIV-Infected Patients (November 2003)
Abstract of a study in the Annals of Pharmacotherapy.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Hepatitis, Mental Illness, and Substance Abuse: Managing the Triple-Diagnosed HIV Patient (July 2003)
Highlights for healthcare professionals from the IAPAC Sessions 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Emerging Toxicity of HIV Therapy? Skeletal Muscle Damage (May 6, 2003)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project - HIV-Positive Man Dies of Kidney Failure and Lactic Acidosis Due to Tenofovir/ddI Interaction (April 8, 2003)
From aidsmap.com - Three French Cases of Tenofovir Kidney Toxicity Reported Amongst HIV-Positive Patients (April 8, 2003)
From aidsmap.com - Drug Interaction: Ritonavir and Fluticasone (November 2001)
Possible link found to Cushing's Syndrome.
In HIV Treatment ALERTS!, from The Center for AIDS - Ingrown Toenails Still a Possible Side Effect (November 2001)
Indinavir-ritonavir interaction is possible culprit.
In HIV Treatment ALERTS!, from The Center for AIDS - Mitochondrial and Mitochondrial-Like Symptoms in Children Born to HIV-Infected Mothers. Exhaustive Evaluation in a Large Prospective Cohort (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |